Spire Wealth Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$936 Hold
51
– – ﹤0.01% 2116
2026
Q2
$744 Buy
+51
New +$492 ﹤0.01% 2175
2022
Q1
– Sell
-50
Closed -$2K – 2753
2021
Q4
$2K Buy
+50
New +$1.96K ﹤0.01% 2789
2021
Q3
– Sell
-700
Closed -$32K – 2624
2021
Q2
$32K Buy
700
+400
+133% +$17.7K ﹤0.01% 1668
2021
Q1
$14K Buy
+300
New +$15.6K ﹤0.01% 2302

Other funds holding NEO

Spire Wealth Management's NEO Position: Q3 2026 in Review

Spire Wealth Management held its NeoGenomics (NEO) position steady in Q3 2026 at 51 shares worth $936. The position accounts for ﹤0.01% of the portfolio, ranked #2116.

Spire Wealth Management first reported a position in NEO in Q1 2021 and has held it in 5 quarters since. The position peaked at $32K in Q2 2021. 157 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Spire Wealth Management held 51 shares of NeoGenomics worth $936 as of Q3 2026.
  • Spire Wealth Management left its NeoGenomics share count unchanged in Q3 2026.
  • NeoGenomics made up ﹤0.01% of Spire Wealth Management's portfolio in Q3 2026, its #2116 holding.
  • Spire Wealth Management first reported a position in NeoGenomics in Q1 2021 and has held it in 5 quarters since.
  • Spire Wealth Management's NeoGenomics position peaked at $32K in Q2 2021.
  • 157 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Spire Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.